Incremental net benefit of extending human papillomavirus vaccine to boys in oropharyngeal cancer burden: Meta-analysis of cost-effectiveness studies

被引:0
作者
Pratama, Adikara Pagan [1 ,2 ]
Chen, Su-Feng [3 ]
Liao, Shih-Chieh [4 ]
Su, Wei-Chia [3 ,5 ]
Yu, Jian-Hong [3 ,6 ]
机构
[1] China Med Univ, Coll Publ Hlth, Dept Publ Hlth, Taichung, Taiwan
[2] Univ Airlangga, Fac Med, Dept Publ Hlth & Prevent Med, Surabaya, Indonesia
[3] China Med Univ, Coll Dent, Sch Dent, 91 Xueshi Rd, Taichung 40402, Taiwan
[4] China Med Univ, Sch Med, Dept Radiol, Taichung, Taiwan
[5] Kaohsiung Chang Gung Mem Hosp, Dept Dent, Div Oral & Maxillofacial Surg, 100,Tzyou 1st Rd, Kaohsiung 80756, Taiwan
[6] China Med Univ Hosp, Dept Dent, Orthodont, Taichung, Taiwan
关键词
Meta-analysis; Oropharyngeal cancer; Incremental cost- effectiveness ratio; Incremental net benefit; HPV VACCINATION; UNITED-STATES; HEALTH; PREVENTION; IMPACT;
D O I
10.1016/j.jds.2024.05.032
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Background/purpose: The incidence of human papillomavirus (HPV)-r elated oropharyngeal cancer (OPC) is increasing worldwide. HPV vaccines have shown efficacy in preventing diseases in both males and females. Therefore, there is a need to develop costeffective strategies for HPV vaccines to prevent HPV-related OPC. This meta-analysis aimed to evaluate cost-effectiveness using the global mean of incremental cost-effectiveness ratios compared to the willingness-to-pay threshold and incremental net benefits (INBs) of HPV vaccination strategies between boys' extension vaccine and girls only. These recommendations will be useful for countries that have not implemented universal HPV vaccines in national programs, such as Taiwan. Materials and methods: Studies evaluating the cost-effectiveness of HPV vaccination strategies in the prevention of OPC that included both sexes versus girls only were identified through the Cochrane Library, EMBASE, PubMed, ScienceDirect, and Web of Science databases on February 05, 2024, and a meta-analysis of pooled INBs was performed using a random effects model. The outcome was an effective measurement of the OPC burden. The results are represented in USD (2024). Results: Fifteen model analyses were included. All the studies were conducted in high-income countries. The global mean of incremental cost-effectiveness ratio was $39,553 (95% CI, $27,008-66,641) per quality-adjusted life years gained, which was below the global mean of the willingness-to-pay threshold of $65,473 (95% CI, $52,138-83,755). Pooled INBs of $9370 (95% CI, $5046-13,695; P < 0.001) favored the extended HPV in boys. Conclusion: HPV vaccination strategies that include boys are cost-effective compared to those with girls only in preventing OPC burden. By implementing a universal HPV vaccination program, countries can receive $9370 in additional monetary benefits per patient. Given its relevance to high-income countries, this study offers key insights that can aid policymakers in Taiwan.
引用
收藏
页码:2045 / 2056
页数:12
相关论文
共 52 条
  • [11] HPV vaccination for prevention of head and neck cancer among men
    El Hussein, Mohamed Toufic
    Dhaliwal, Simreen
    [J]. NURSE PRACTITIONER, 2023, 48 (10) : 25 - 32
  • [12] Impact of vaccinating boys and men against HPV in the United States
    Elbasha, Elamin H.
    Dasbach, Erik J.
    [J]. VACCINE, 2010, 28 (42) : 6858 - 6867
  • [13] Equity in digital healthcare - the case of Denmark
    Eriksen, Jeppe
    Ebbesen, Mette
    Eriksen, Kristina Tornbjerg
    Hjermitslev, Camilla
    Knudsen, Casper
    Bertelsen, Pernille
    Nohr, Christian
    Weber, Ditte
    [J]. FRONTIERS IN PUBLIC HEALTH, 2023, 11
  • [14] The effects of the national HPV vaccination programme in England, UK, on cervical cancer and grade 3 cervical intraepithelial neoplasia incidence: a register-based observational study
    Falcaro, Milena
    Castanon, Alejandra
    Ndlela, Busani
    Checchi, Marta
    Soldan, Kate
    Lopez-Bernal, Jamie
    Elliss-Brookes, Lucy
    Sasieni, Peter
    [J]. LANCET, 2021, 398 (10316) : 2084 - 2092
  • [15] Global prevalence of human papillomavirus-related oral and oropharyngeal squamous cell carcinomas: a systematic review and meta-analysis
    Fonseca, Thamyres Campos
    Jural, Lucas Alves
    Maranon-Vasquez, Guido Artemio
    Magno, Marcela Barauna
    Roza, Ana Luiza Oliveira Correa
    Ferreira, Daniele Masterson Tavares Pereira
    Maia, Lucianne Cople
    Romanach, Mario Jose
    Agostini, Michelle
    Abrahao, Aline Correa
    [J]. CLINICAL ORAL INVESTIGATIONS, 2023, 28 (01)
  • [16] Pricing of HPV Vaccines in Europe: Back to the Future?
    Garattini, Livio
    Padula, Anna
    [J]. APPLIED HEALTH ECONOMICS AND HEALTH POLICY, 2018, 16 (03) : 275 - 277
  • [17] A cost-effectiveness analysis of human papillomavirus vaccination of boys for the prevention of oropharyngeal cancer
    Graham, Donna M.
    Isaranuwatchai, Wanrudee
    Habbous, Steven
    de Oliveira, Claire
    Liu, Geoffrey
    Siu, Lillian L.
    Hoch, Jeffrey S.
    [J]. CANCER, 2015, 121 (11) : 1785 - 1792
  • [18] Grandahl M, 2019, HUM VACC IMMUNOTHER, V15, P1794, DOI 10.1080/21645515.2018.1551670
  • [19] Cost-Effectiveness Analysis of Universal Human Papillomavirus Vaccination Using a Dynamic Bayesian Methodology: The BEST II Study
    Haeussler, Katrin
    Marcellusi, Andrea
    Mennini, Francesco Saverio
    Favato, Giampiero
    Picardo, Mauro
    Garganese, Giorgia
    Bononi, Marco
    Costa, Silvano
    Scambia, Giovanni
    Zweifel, Peter
    Capone, Alessandro
    Baio, Gianluca
    [J]. VALUE IN HEALTH, 2015, 18 (08) : 956 - 968
  • [20] Systematic Review and Meta-Analysis of Cost-effectiveness of Rotavirus Vaccine in Low-Income and Lower-Middle-Income Countries
    Haider, Sabbir
    Chaikledkaew, Usa
    Thavorncharoensap, Montarat
    Youngkong, Sitaporn
    Islam, Md Ashadul
    Thakkinstian, Ammarin
    [J]. OPEN FORUM INFECTIOUS DISEASES, 2019, 6 (04):